MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
24.49
+1.33 (5.74%)
Sep 26, 2024, 4:00 PM EDT - Market closed
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $817.57 million as of September 26, 2024.
Market Cap
817.57M
Enterprise Value
914.91M
1-Year Change
n/a
Ranking
Category
Stock Price
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $817.57M, an increase of 60.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2024 | 698.40M | 37.03% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dianthus Therapeutics | 783.47M |
| Terns Pharmaceuticals | 780.70M |
| Alphatec Holdings | 779.55M |
| ArriVent BioPharma | 776.17M |
| Erasca | 773.72M |
| Bioventus | 757.47M |
| Replimune Group | 756.32M |
| Rapport Therapeutics | 743.23M |